ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
6
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
4,848
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Tiotropium Respimat increases the risk of mortality.
Author(s):
Christine R Jenkins
,
Richard Beasley
Publication date
(Electronic):
Jan 2013
Journal:
Thorax
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
IUCN Red List of Ecosystems
Author and article information
Journal
Journal ID (iso-abbrev):
Thorax
Title:
Thorax
ISSN (Electronic):
1468-3296
ISSN (Print):
0040-6376
Publication date (Electronic):
Jan 2013
Volume
: 68
Issue
: 1
Article
Publisher Item ID:
thoraxjnl-2012-202482
DOI:
10.1136/thoraxjnl-2012-202482
PubMed ID:
23229813
SO-VID:
01838f6d-522e-421b-b7c9-4709ca6b3d8b
History
Data availability:
Comments
Comment on this article
Sign in to comment
Related Documents Log
scite_
Similar content
4,848
The 24-hour FEV1time profile of olodaterol once daily (QD) via Respimat® and formoterol twice daily (BID) via Aerolizer® in patients with COPD: results from two 6-week studies
Authors:
G Feldman
,
J Messerges-Bernstein
,
AL Hamilton
…
Comprehensive assessment of the safety of olodaterol 5 μg in the Respimat® device for maintenance treatment of COPD: comparison with the long-acting beta2-agonist formoterol
Authors:
A. Koch
,
H WATZ
,
MR Maleki-Yazdi
Dose-finding study for tiotropium and olodaterol when administered in combination via the Respimat® inhaler in patients with COPD
Authors:
R Aalbers
,
MR Maleki
,
W. Hamilton
See all similar
Cited by
6
The Prospective Non-Interventional DACCORD Study in the National COPD Registry in Germany: design and methods
Authors:
Peter Kardos
,
Claus Vogelmeier
,
Roland Buhl
…
Tiotropium Bromide in Chronic Obstructive Pulmonary Disease and Bronchial Asthma
Authors:
Alcibey Alvarado-Gonzalez
,
Isabel Arce
Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort study
Authors:
Francesco Trotta
,
Stefania Spila-Alegiani
,
Roberto Da Cas
…
See all cited by